These activities of FGF21 and possibly FGF19 on adipocytes that elicit tumor suppressive metabolic signals appear sufficient to override tumor-promoting effects of elevated bile acids, inflammation and mild metabolic abnormalities elicited by the FGFR4 deficiency. This evidence concerns the gene FGFR4 and neoplasm.